Clinical trial

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

NCT07403266

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention YCJ-01 Full Spectrum cannbis Extract Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-06-01

PhasePHASE3

Conditions

Tuberous Sclerosis Complex (TSC)unresolved

Interventions

YCJ-01 Full Spectrum cannbis ExtractDRUG

PlaceboDRUG

Sponsors & collaborators

Oils4Curelead sponsor

Mapped research locations

MadridSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07403266 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.